Status:
UNKNOWN
Comparing Topical Tetracaine Drops to Topical Focal Phenol for Local Anesthesia During Intratympanic Steroid Injection
Lead Sponsor:
Our Lady of the Lake Hospital
Collaborating Sponsors:
Louisiana State University Health Sciences Center - New Orleans
Conditions:
Intratympanic Steroid Injection
Idiopathic Sudden Sensorineural Hearing Loss
Eligibility:
All Genders
18+ years
Phase:
EARLY_PHASE1
Brief Summary
Intratympanic steroid injections are an accepted treatment for Meniere's disease and idiopathic sudden sensorineural hearing loss. This treatment is typically performed using local topical anesthesia....
Eligibility Criteria
Inclusion
- Adult subjects (18 years of age or greater)
- Diagnosed with Idiopathic Sudden Sensorineural hearing loss or Meniere's disease
- Care plan includes treatment via intratympanic steroid injection
Exclusion
- Having a current tympanic membrane perforation
- Adults unable to sign written consent
- Individuals less than 18 years of age
- Pregnant women
- Prisoners
Key Trial Info
Start Date :
August 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2023
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04794842
Start Date
August 1 2021
End Date
December 31 2023
Last Update
October 31 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Our Lady of the Lake Hospital
Baton Rouge, Louisiana, United States, 70808